Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2021 Publisher: Ipca Pharma (NZ) Pty Limited, PO Box 74509, Auckland 1546 +64 2136 0880 in New Zealand or +61 3 98856172 in Australia
Pacimol, paracetamol 500 mg, uncoated tablets.
| Pharmaceutical Form |
|---|
|
White, capsule shaped, biconvex uncoated tablet with break line on one side. |
Active ingredient: Paracetamol (BP) 500 mg/tablet.
Excipient(s) with known effect: For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Paracetamol |
Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain. |
| List of Excipients |
|---|
|
Pregelatinised starch |
Blister pack of 1000 tablets.
Ipca Pharma (NZ) Pty Limited, PO Box 74509, Auckland 1546
+64 2136 0880 in New Zealand or
+61 3 98856172 in Australia
Date of first approval: October 2020
| Drug | Countries | |
|---|---|---|
| PACIMOL | Hong Kong, New Zealand, Turkey, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
